Gregory R. Jackson, PhD, Co-founder and Chief Technology Officer
Dr. Jackson is the principal inventor of the company’s AdaptDx® technology. He previously held joint appointments in Ophthalmology and Neural & Behavioral Sciences at the Penn State College of Medicine and was Director of Clinical Research for Ophthalmology. Dr. Jackson has specialized in dark adaptation for the past 20 years, publishing a dozen journal articles on this topic. He earned a BS in psychology from Clarion University and a PhD in behavioral neuroscience from University of Alabama at Birmingham.